Results from phase II trial of HSP90 inhibitor, STA-9090...

Melanoma Research 2018 / 12 Vol. 28; Iss. 6

Results from phase II trial of HSP90 inhibitor, STA-9090 (ganetespib), in metastatic uveal melanoma

Shah, Shalin, Luke, Jason J., Jacene, Heather A., Chen, Tianqi, Giobbie-Hurder, Anita, Ibrahim, Nageatte, Buchbinder, Elizabeth L., McDermott, David F., Flaherty, Keith T., Sullivan, Ryan J., Lawrence
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
28
Language:
english
Journal:
Melanoma Research
DOI:
10.1097/CMR.0000000000000509
Date:
December, 2018
File:
PDF, 201 KB
english, 2018
Conversion to is in progress
Conversion to is failed